Literature DB >> 30215218

Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model.

Kai Zhang1,2, Hidetoh Toki3, Yuko Fujita1, Min Ma1, Lijia Chang1, Youge Qu1, Shingo Harada4, Tetsuhiro Nemoto4, Akiko Mizuno-Yasuhira3, Jun-Ichi Yamaguchi3, Shigeyuki Chaki3, Kenji Hashimoto5.   

Abstract

RATIONALE: (R,S)-ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, exhibits rapid and long-lasting antidepressant effects and anti-suicidal ideation in treatment-resistant patients with depression. However, the precise mechanisms underlying the antidepressant actions of (R,S)-ketamine are unknown. Although the previous report demonstrated the deuterium isotope effects in the antidepressant actions of (R,S)-ketamine, the deuterium isotope effects in the antidepressant actions of (R)-ketamine, which is more potent than (S)-ketamine, are unknown.
METHODS: We examined whether deuterium substitution at the C6 position could affect antidepressant effects of (R)-ketamine in a chronic social defeat stress (CSDS) model.
RESULTS: Pharmacokinetic studies showed that levels of (2R,6R)-d1-hydroxynorketamine [(2R,6R)-d1-HNK], a final metabolite of (R)-d2-ketamine, in the plasma and brain after administration of (R)-d2-ketamine (10 mg/kg) were lower than those of (2R,6R)-HNK from (R)-ketamine (10 mg/kg), indicating deuterium isotope effects in the production of (2R,6R)-HNK. In contrast, levels of (R)-ketamine and its metabolite (R)-norketamine in the plasma and brain were the same for both compounds. In a CSDS model, both (R)-ketamine (10 mg/kg) and (R)-d2-ketamine (10 mg/kg) showed rapid and long-lasting (7 days) antidepressant effects, indicating no deuterium isotope effect in the antidepressant effects of (R)-ketamine.
CONCLUSIONS: The present study suggests that deuterium substitution of hydrogen at the C6 position slows the metabolism from (R)-ketamine to (2R,6R)-HNK in mice. In contrast, we did not find the deuterium isotope effects in terms of the rapid and long-lasting antidepressant effects of (R)-ketamine in a CSDS model. Therefore, it is unlikely that (2R,6R)-HNK is essential for antidepressant effects of (R)-ketamine.

Entities:  

Keywords:  (2R,6R)-hydroxynorketamine; (R)-ketamine; Deuterium isotope effect; Metabolism

Mesh:

Substances:

Year:  2018        PMID: 30215218     DOI: 10.1007/s00213-018-5017-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  48 in total

Review 1.  Antidepressant actions of ketamine: from molecular mechanisms to clinical practice.

Authors:  Lisa M Monteggia; Carlos Zarate
Journal:  Curr Opin Neurobiol       Date:  2015-01-03       Impact factor: 6.627

2.  Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression.

Authors:  Yukihiko Shirayama; Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-01       Impact factor: 5.270

3.  Ketamine's antidepressant action: beyond NMDA receptor inhibition.

Authors:  Kenji Hashimoto
Journal:  Expert Opin Ther Targets       Date:  2016-09-28       Impact factor: 6.902

4.  (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice.

Authors:  Jun-Ichi Yamaguchi; Hidetoh Toki; Youge Qu; Chun Yang; Hiroyuki Koike; Kenji Hashimoto; Akiko Mizuno-Yasuhira; Shigeyuki Chaki
Journal:  Neuropsychopharmacology       Date:  2018-05-03       Impact factor: 7.853

Review 5.  How does ketamine elicit a rapid antidepressant response?

Authors:  Ege T Kavalali; Lisa M Monteggia
Journal:  Curr Opin Pharmacol       Date:  2014-11-25       Impact factor: 5.547

6.  Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.

Authors:  Ronald S Duman; George K Aghajanian; Gerard Sanacora; John H Krystal
Journal:  Nat Med       Date:  2016-03       Impact factor: 53.440

7.  Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys.

Authors:  Kenji Hashimoto; Takeharu Kakiuchi; Hiroyuki Ohba; Shingo Nishiyama; Hideo Tsukada
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-18       Impact factor: 5.270

8.  Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model.

Authors:  Chun Yang; Youge Qu; Yuko Fujita; Qian Ren; Min Ma; Chao Dong; Kenji Hashimoto
Journal:  Transl Psychiatry       Date:  2017-12-18       Impact factor: 6.222

9.  Role of Inflammatory Bone Markers in the Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model.

Authors:  Kai Zhang; Min Ma; Chao Dong; Kenji Hashimoto
Journal:  Int J Neuropsychopharmacol       Date:  2018-11-01       Impact factor: 5.176

10.  No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model.

Authors:  Lijia Chang; Hidetoh Toki; Youge Qu; Yuko Fujita; Akiko Mizuno-Yasuhira; Jun-Ichi Yamaguchi; Shigeyuki Chaki; Kenji Hashimoto
Journal:  Int J Neuropsychopharmacol       Date:  2018-10-01       Impact factor: 5.176

View more
  6 in total

Review 1.  Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications.

Authors:  Jaclyn N Highland; Panos Zanos; Lace M Riggs; Polymnia Georgiou; Sarah M Clark; Patrick J Morris; Ruin Moaddel; Craig J Thomas; Carlos A Zarate; Edna F R Pereira; Todd D Gould
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 2.  Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.

Authors:  Kenji Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2019-07-11       Impact factor: 5.188

3.  Effect of the deuterium on efficiency and type of adipogenic differentiation of human adipose-derived stem cells in vitro.

Authors:  Alona V Zlatska; Roman G Vasyliev; Inna M Gordiienko; Anzhela E Rodnichenko; Maria A Morozova; Maria A Vulf; Dmytro O Zubov; Svitlana N Novikova; Larisa S Litvinova; Tatiana V Grebennikova; Igor A Zlatskiy; Anton V Syroeshkin
Journal:  Sci Rep       Date:  2020-03-23       Impact factor: 4.379

Review 4.  Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites.

Authors:  Chun Yang; Jianjun Yang; Ailin Luo; Kenji Hashimoto
Journal:  Transl Psychiatry       Date:  2019-11-07       Impact factor: 6.222

5.  Deuterium-Depleted Water as Adjuvant Therapeutic Agent for Treatment of Diet-Induced Obesity in Rats.

Authors:  Tetiana Halenova; Igor Zlatskiy; Anton Syroeshkin; Tatiana Maximova; Tatiana Pleteneva
Journal:  Molecules       Date:  2019-12-19       Impact factor: 4.411

6.  Dependence of Biocatalysis on D/H Ratio: Possible Fundamental Differences for High-Level Biological Taxons.

Authors:  Igor Zlatskiy; Tatiana Pleteneva; Alexander Skripnikov; Tatiana Grebennikova; Tatiana Maksimova; Nadine Antipova; Olga Levitskaya; Mariia Makarova; Igor Selivanenko; Anton Syroeshkin
Journal:  Molecules       Date:  2020-09-11       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.